How long does reflux last

Pro Research Analysisby

Searched over 200M research papers

Analyzed relevant papers

Duration of Reflux: Insights from Recent Research

Vesicoureteral Reflux in Children: Long-Term Outcomes

Medical Treatment and Reflux Resolution

Vesicoureteral reflux (VUR) in children, particularly severe cases (grades III and IV), has been extensively studied. A significant study involving 401 children revealed that VUR can resolve over time with medical treatment. Specifically, 28% of children with newly detected VUR experienced resolution within five years. However, for those with VUR detected more than a year before the study, only 6% saw resolution after five years. The study also highlighted that unilateral VUR resolved more frequently (54%) compared to bilateral VUR (12%) .

Gastroesophageal Reflux Disease (GERD): Symptom Persistence and Management

Five-Year Symptom Follow-Up

A longitudinal study on patients with reflux symptoms and reflux esophagitis (RE) found that reflux symptoms often diminish over time. After five years, only 26% of patients who initially had reflux symptoms continued to experience them. This suggests that reflux symptoms frequently disappear within a five-year period, although predicting which individuals will remain symptomatic is challenging .

Long-Term Outcomes of Antireflux Surgery

Comparative studies between laparoscopic antireflux surgery (LARS) and long-term esomeprazole therapy have shown that both treatments significantly reduce esophageal acid exposure over five years. However, LARS was more effective in maintaining reduced acid exposure compared to esomeprazole. This indicates that surgical intervention may offer more sustained relief from acid reflux symptoms .

Extended Follow-Up of GERD Patients

A study with a follow-up period of 17-22 years on patients with severe GERD managed conservatively (without H2-antagonists or omeprazole) found that while symptoms generally decreased over time, pathological reflux persisted in most patients. This underscores that while symptom severity may lessen, the underlying reflux condition often remains, necessitating ongoing management .

Reflux in Infants: Natural Course

Physiological Reflux in Infants

In infants, gastroesophageal reflux is a common physiological phenomenon. A study involving 509 healthy infants monitored over 24 hours found that the reflux index, which measures the percentage of time with a pH less than 4, decreases from 13% at birth to 8% by 12 months. This indicates that reflux naturally diminishes as infants grow older .

Conclusion

The duration and persistence of reflux vary significantly depending on the type and severity of the condition, as well as the age of the patients. In children with vesicoureteral reflux, resolution can occur within five years, particularly with medical treatment. For adults with GERD, symptoms often decrease over time, but the condition itself may persist, requiring long-term management. In infants, reflux is a common and typically self-limiting condition that improves with age. Understanding these patterns can help in managing expectations and treatment plans for patients with reflux conditions.

Sources and full results

Most relevant research papers on this topic

Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children.

Medical treatment for vesicoureteral reflux in children can lead to a significant cessation rate after 5 years, with no significant difference between grades III and IV.

RCTLarge Human Trial

1992·

162citations

·T. Tamminen-Möbius et al.

The Journal of urology·

DOI

Five-year follow-up study of patients with reflux symptoms and reflux esophagitis in annual medical check-up field.

Reflux symptoms often disappear after 5 years, making it difficult to identify individuals who will still have symptoms based on clinical characteristics.

2008·

8citations

·T. Azumi et al.

Internal medicine·

DOI

Gastroesophageal reflux, as measured by 24-hour pH monitoring, in 509 healthy infants screened for risk of sudden infant death syndrome.

The normal range for gastroesophageal reflux in healthy infants is about 10% during the first 12 months of life, decreasing from 13% at birth to 8% at 12 months.

1991·

295citations

·Y. Vandenplas et al.

Pediatrics·

DOI

Long‐term symptom control of gastro‐oesophageal reflux disease 12 years after laparoscopic Nissen or 180° anterior partial fundoplication in a randomized clinical trial

Laparoscopic 180° anterior fundoplication provides similar long-term symptom control to Nissen fundoplication for gastro-oesophageal reflux disease, with fewer side-effects.

RCTRigorous Journal

2017·

33citations

·D. Roks et al.

British Journal of Surgery·

DOI

Gastroesophageal Acid Reflux Control 5 Years After Antireflux Surgery, Compared With Long-term Esomeprazole Therapy.

Laparoscopic antireflux surgery (LARS) significantly reduces 24-hour esophageal acid exposure in chronic GERD patients over 5 years, while esomeprazole therapy effectively controls symptoms.

RCT

2016·

62citations

·J. Hatlebakk et al.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·

DOI

Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients.

The severity of symptoms declines in long-term conservatively treated gastroesophageal reflux disease patients, but pathological reflux persists, highlighting the need for tailored therapy.

1997·

204citations

·J. Isolauri et al.

The American journal of gastroenterology

Evaluation of reflux following sleeve gastrectomy and one anastomosis gastric bypass: 1-year results from a randomized open-label controlled trial

Laparoscopic sleeve gastrectomy (LSG) is recommended for patients with preoperative subclinical reflux or low grade (A) esophagitis due to higher acid exposure time and esophagitis rate compared to Mini-/One anastomosis gastric bypass (

RCTRigorous Journal

2020·

48citations

·M. Musella et al.

Surgical Endoscopy·

DOI

Six to 12-year outcomes of magnetic sphincter augmentation for gastroesophageal reflux disease

Magnetic sphincter augmentation (MSA) is a safe and effective treatment for gastroesophageal reflux disease, improving symptoms, decreasing drug dependency, and reducing esophageal acid exposure over 6-12 years.

Rigorous Journal

2020·

52citations

·Davide Ferrari et al.

Scientific Reports·

DOI

Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life.

Nearly three-quarters of patients with oesophagitis still have significant morbidity related to gastro-oesophageal reflux disease more than 10 years after diagnosis, with some quality of life scores significantly lower than the general population.

1996·

222citations

·N. McDougall et al.

Gut·

DOI

Ten-year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children

Children with severe vesicoureteral reflux progressed well under both medical and surgical management, with close supervision and prompt treatment of recurrences.

RCT

2006·

231citations

·U. Jodal et al.

Pediatric Nephrology·

DOI

Try another search

signs of fentanyl

medical treatment for heart failure

does gabapentin cause you to gain weight

pepto bismol for upset stomach

hottest years on record

how do greenhouse gases contribute to global warming